23 related articles for article (PubMed ID: 29465348)
1. Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity.
Klimek E; Mikołajczyk T; Sulicka J; Kwaśny-Krochin B; Korkosz M; Osmenda G; Wizner B; Surdacki A; Guzik T; Grodzicki TK; Skalska A
Biomed Res Int; 2014; 2014():736853. PubMed ID: 25126574
[TBL] [Abstract][Full Text] [Related]
2. Serum Cytokine Profiles in Patients with Rheumatoid Arthritis Before and After Treatment with Methotrexate.
Lama M; Sarkar R; Ghosh B
J Interferon Cytokine Res; 2023 Aug; 43(8):344-350. PubMed ID: 37566477
[TBL] [Abstract][Full Text] [Related]
3. Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
Yoshida H; Magi M; Tamai H; Kikuchi J; Yoshimoto K; Otomo K; Matsumoto Y; Noguchi-Sasaki M; Takeuchi T; Kaneko Y
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38530780
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
Talmon M; Percio M; Obeng JA; Ruffinatti FA; Sola D; Sainaghi PP; Bellis E; Cusinato S; Ianniello A; Fresu LG
PLoS One; 2023; 18(3):e0282564. PubMed ID: 36877690
[TBL] [Abstract][Full Text] [Related]
5. Multicohort Analysis Identifies Monocyte Gene Signatures to Accurately Monitor Subset-Specific Changes in Human Diseases.
Vallania F; Zisman L; Macaubas C; Hung SC; Rajasekaran N; Mason S; Graf J; Nakamura M; Mellins ED; Khatri P
Front Immunol; 2021; 12():659255. PubMed ID: 34054824
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of 14-3-3η are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients.
Tu J; Chen X; Dai M; Pan A; Liu C; Zhou Y; Xia X; Sun L
Exp Ther Med; 2020 Aug; 20(2):754-761. PubMed ID: 32742321
[TBL] [Abstract][Full Text] [Related]
7. Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis.
Hirose S; Lin Q; Ohtsuji M; Nishimura H; Verbeek JS
Int Immunol; 2019 Oct; 31(11):687-696. PubMed ID: 31063541
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate: mechanism of action in rheumatoid arthritis.
Segal R; Yaron M; Tartakovsky B
Semin Arthritis Rheum; 1990 Dec; 20(3):190-200. PubMed ID: 2287944
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.
Tsukamoto M; Suzuki K; Seta N; Takeuchi T
Clin Exp Rheumatol; 2018; 36(4):540-544. PubMed ID: 29465348
[TBL] [Abstract][Full Text] [Related]
10. CD14
Tsukamoto M; Seta N; Yoshimoto K; Suzuki K; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Feb; 19(1):28. PubMed ID: 28183329
[TBL] [Abstract][Full Text] [Related]
11. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
[TBL] [Abstract][Full Text] [Related]
12. TNF-α Inhibitors Decrease Classical CD14
Batko B; Schramm-Luc A; Skiba DS; Mikolajczyk TP; Siedlinski M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642076
[TBL] [Abstract][Full Text] [Related]
13. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.
Coulthard LR; Geiler J; Mathews RJ; Church LD; Dickie LJ; Cooper DL; Wong C; Savic S; Bryer D; Buch MH; Emery P; Morgan AW; McDermott MF
Clin Exp Immunol; 2012 Oct; 170(1):36-46. PubMed ID: 22943199
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
